| RS1672815555 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1672818590 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1672820246 |
SLC3A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Cystinuria, Cystinuria |
| RS1672822541 |
LRPPRC
|
Health Risk |
Likely pathogenic |
Congenital lactic acidosis, Saguenay-Lac-Saint-Jean type |
| RS1672830111 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1672830765 |
MSH2
|
Health Risk |
Pathogenic |
Lynch syndrome 1, Lynch syndrome 1 |
| RS1672863537 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS1672866585 |
FBXO11
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder, Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities |
| RS1672907018 |
SUCLG1
|
Health Risk |
Pathogenic |
Mitochondrial DNA depletion syndrome 9, Mitochondrial DNA depletion syndrome 9 |
| RS1672918134 |
HADHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial trifunctional protein deficiency, Mitochondrial trifunctional protein deficiency |
| RS1672919182 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS1672921868 |
FAM161A
|
Health Risk |
Pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1672928309 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS1672931057 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS1672934629 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1672938022 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS1672942991 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1672945766 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1 |
| RS1672946564 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1672946845 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1672947148 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colon cancer |
| RS1672947913 |
FAM161A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa 28, Retinitis pigmentosa 28 |
| RS1672948970 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS1672950651 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS1672951706 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1 |
| RS1672953209 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS1672953502 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS1672955848 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1 |
| RS1672956184 |
MSH2
|
Health Risk |
Pathogenic |
Lynch-like syndrome, Lynch-like syndrome |
| RS1672957185 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1672958391 |
MSH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Lynch syndrome, Hereditary cancer-predisposing syndrome |
| RS1672959153 |
HADHB
|
Health Risk |
Likely pathogenic |
Mitochondrial trifunctional protein deficiency, Mitochondrial trifunctional protein deficiency |
| RS1672964092 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1672964817 |
FAM161A
|
Health Risk |
Pathogenic |
— |
| RS1672973685 |
ALMS1
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS1672976991 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1672982825 |
FAM161A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 28, Retinitis pigmentosa 28 |
| RS1672986669 |
PREPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Myasthenic syndrome, congenital |
| RS1673040470 |
FAM161A
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 28, Retinitis pigmentosa 28 |
| RS1673064965 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1673065619 |
DNMT3A
|
Health Risk |
Pathogenic |
DNMT3A-related disorder, DNMT3A-related disorder |
| RS1673066717 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary nonpolyposis colorectal neoplasms |
| RS1673067879 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1673070318 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1 |
| RS1673072429 |
MSH2
|
Health Risk |
Pathogenic |
Lynch-like syndrome, Lynch-like syndrome |
| RS1673074932 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Lynch syndrome 1 |
| RS1673078633 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1 |
| RS1673079599 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1673082068 |
MSH2
|
Health Risk |
Pathogenic |
— |
| RS1673083690 |
MSH2
|
Health Risk |
Likely pathogenic |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1 |
| RS1673092558 |
MATN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple epiphyseal dysplasia type 5, Multiple epiphyseal dysplasia type 5 |
| RS1673102663 |
MATN3
|
Health Risk |
Likely pathogenic |
Multiple epiphyseal dysplasia type 5, Multiple epiphyseal dysplasia type 5 |
| RS1673116593 |
PREPL
|
Health Risk |
Likely pathogenic |
— |
| RS1673136181 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS1673169930 |
PREPL
|
Health Risk |
Likely pathogenic |
Myasthenic syndrome, congenital |
| RS1673171921 |
AKT3
|
Health Risk |
Pathogenic |
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2, Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2 |
| RS1673189476 |
WDR26
|
Health Risk |
Pathogenic/Likely pathogenic |
Skraban-Deardorff syndrome, Skraban-Deardorff syndrome |
| RS1673192650 |
WDR26
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1673217321 |
LPIN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Myoglobinuria, acute recurrent |
| RS1673229720 |
NPHS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Steroid-resistant nephrotic syndrome, Nephrotic syndrome |
| RS1673254835 |
NPHS2
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephrotic syndrome, type 2 |
| RS1673255837 |
NPHS2
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 2 |
| RS1673263416 |
LYST
|
Health Risk |
Pathogenic/Likely pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS1673264509 |
NPHS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephrotic syndrome, type 2 |
| RS1673288090 |
RIT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Noonan syndrome 8, Cardiovascular phenotype |
| RS1673318855 |
RPIA
|
Health Risk |
Pathogenic |
Deficiency of ribose-5-phosphate isomerase, Deficiency of ribose-5-phosphate isomerase |
| RS1673322799 |
WDR26
|
Health Risk |
Pathogenic |
Intellectual disability, Intellectual disability |
| RS1673323181 |
WDR26
|
Health Risk |
Pathogenic |
— |
| RS1673333616 |
WDR26
|
Health Risk |
Likely pathogenic |
Skraban-Deardorff syndrome, Skraban-Deardorff syndrome |
| RS1673398956 |
RIT1
|
Health Risk |
Likely pathogenic |
Noonan syndrome, Noonan syndrome 8 |
| RS1673399238 |
RIT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Noonan syndrome 8, Cardiovascular phenotype |
| RS1673479296 |
NBAS
|
Health Risk |
Likely pathogenic |
Infantile liver failure syndrome 2, Infantile liver failure syndrome 2 |
| RS1673531830 |
KIDINS220
|
Health Risk |
Pathogenic |
KIDINS220-related disorder, KIDINS220-related disorder |
| RS1673545403 |
MSTO1
|
Health Risk |
Pathogenic |
Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome, Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome |
| RS1673549822 |
PREPL
|
Health Risk |
Pathogenic/Likely pathogenic |
Myasthenic syndrome, congenital |
| RS1673582111 |
KLHL20
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, Neurodevelopmental disorder |
| RS1673617254 |
MSTO1
|
Health Risk |
Pathogenic |
— |
| RS1673619175 |
TTC7A
|
Health Risk |
Likely pathogenic |
Multiple gastrointestinal atresias, Multiple gastrointestinal atresias |
| RS1673628520 |
LYST
|
Health Risk |
Pathogenic |
Chédiak-Higashi syndrome, Chédiak-Higashi syndrome |
| RS1673643995 |
ALMS1
|
Health Risk |
Pathogenic |
— |
| RS1673664656 |
WDPCP
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome 15, Bardet-Biedl syndrome 15 |
| RS1673720739 |
LPIN1
|
Health Risk |
Pathogenic |
— |
| RS1673733539 |
WDR26
|
Health Risk |
Pathogenic |
Skraban-Deardorff syndrome, Skraban-Deardorff syndrome |
| RS1673747823 |
LPIN1
|
Health Risk |
Pathogenic |
— |
| RS1673789444 |
NPHS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephrotic syndrome, type 2 |
| RS1673843345 |
ALG14
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual developmental disorder with epilepsy, behavioral abnormalities |
| RS1673920358 |
LRPPRC
|
Health Risk |
Pathogenic |
— |
| RS1673926348 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome 1 |
| RS1673928022 |
MSH2
|
Health Risk |
Pathogenic |
Lynch-like syndrome, Lynch-like syndrome |
| RS1673931379 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1673938031 |
MSH2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1673943931 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1673945046 |
LRPPRC
|
Health Risk |
Pathogenic |
— |
| RS1673948297 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1673949938 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1673950263 |
MSH2
|
Health Risk |
Pathogenic |
Lynch-like syndrome, Lynch-like syndrome |
| RS1673951492 |
MSH2
|
Health Risk |
Pathogenic |
Lynch-like syndrome, Lynch-like syndrome |
| RS1673951633 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Muir-Torré syndrome |
| RS1673954981 |
NPHS2
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, type 2 |
| RS1673963444 |
WDR26
|
Health Risk |
Pathogenic |
Skraban-Deardorff syndrome, Skraban-Deardorff syndrome |